Feasibility and ethical issues: experiences and concerns of healthcare workers regarding a new RSV prophylaxis programme in Nunavik, Quebec

Background: The respiratory syncytial virus (RSV) is a major cause of hospitalisation in young Inuit children. Prophylaxis with palivizumab is routinely recommended for premature infants and those with severe pulmonary or cardiac diseases. In the fall 2016, the Quebec Ministry of Health expanded the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Armelle Lorcy, Rodica Gilca, Eve Dubé, Marie Rochette, Gaston De Serres
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2020-01-01
coleção:	International Journal of Circumpolar Health
Assuntos:	respiratory syncytial virus palivizumab health-care workers experiences opinions inuit health services
Acesso em linha:	http://dx.doi.org/10.1080/22423982.2020.1742564
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!